ArticleJournal of nanobiotechnology2026
A programmable peptide interface for on-demand neural culturing platforms.
Article in Journal of nanobiotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
The precise spatial organization of neural cells into two-dimensional networks or three-dimensional spheroids is crucial for advancing neuroscience research and drug discoveries, yet remains challenging with conventional, single-function coatings. Here, we propose a programmable bifunctional peptide that integrates a silica-binding domain with a tunable cell-adhesive Arginine-Glycine-Aspartate (RGD) tripeptide. By systematically improving the RGD variant and linker rigidity, we introduced a single coating material that enables on-demand switching between two distinct functions: guiding the patterned growth of functional neural circuits on glass and facilitating the high-throughput formation of uniform neural spheroids. The latter exhibited high viability, extensive neurite outgrowth, and spontaneous electrophysiological activity, which validates their functional maturity. We establish by this work a versatile and reliable platform for advanced neural interface research, with significant potential for drug discovery and disease modeling.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.